Old Web
English
Sign In
Acemap
>
authorDetail
>
Kenneth Lasseter
Kenneth Lasseter
Novartis
Pharmacokinetics
Medicine
Anesthesia
Pharmacology
Cmax
5
Papers
173
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety, and tolerability of relebactam combined with imipenem and cilastatin
2020
British Journal of Clinical Pharmacology
Pratik Bhagunde
Francheska Colon-Gonzalez
Yang Liu
Jin Wu
Shiyao Sherrie Xu
Graigory Garrett
Patricia Jumes
Kenneth Lasseter
Thomas Marbury
Matthew L. Rizk
Mallika Lala
Elizabeth G. Rhee
Joan R. Butterton
Keith Boundy
Show All
Source
Cite
Save
Citations (4)
FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment
2005
The Journal of Clinical Pharmacology
John M. Kovarik
Robert Schmouder
Denise Serra
Y. Wang
H. Wiegand
S. C. Dilzer
Kenneth Lasseter
Show All
Source
Cite
Save
Citations (18)
Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects.
2001
The Journal of Clinical Pharmacology
Honghui Zhou
Suzanne Khalilieh
Katenka Svendsen
F. Pommier
Stuart Osborne
Silke Appel-Dingemanse
Kenneth Lasseter
James F. McLeod
Show All
Source
Cite
Save
Citations (12)
Interactions between Simvastatin and Troglitazone or Pioglitazone in Healthy Subjects
2001
The Journal of Clinical Pharmacology
Thomayant Prueksaritanont
José M. Vega
Jamie Zhao
Kathleen Gagliano
Olga Kuznetsova
Bret Musser
Raju D. Amin
Lida Liu
Brad A. Roadcap
Stacy Dilzer
Kenneth Lasseter
J. Douglas Rogers
Show All
Source
Cite
Save
Citations (52)
Influence of hepatic impairment on everolimus pharmacokinetics: implications for dose adjustment.
2001
Clinical Pharmacology & Therapeutics
John M. Kovarik
Helene Sabia
Joaquim Figueiredo
Heidrun Zimmermann
Christine Reynolds
Stacy C. Dilzer
Kenneth Lasseter
Christiane Rordorf
Show All
Source
Cite
Save
Citations (87)
1